Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A, and soluble E-selectin

Hypertension in Pregnancy

Volumn 22, Issue 1, 2003, Pages 45-55

  Bersinger, Nick A ^a,f   Smárason, Alexander K ^b,d   Muttukrishna, Shanthi ^b,e   Groome, Nigel P ^c   Redman, Christopher W ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

^d Akureyri Central Hospital   (Iceland)

^e ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^f DKF   (Switzerland)

Author keywords

Endothelial selectin; Preeclampsia; Pregnancy associated plasma protein A

Indexed keywords

ACTIVIN A; BIOCHEMICAL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INHIBIN A; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; MATERNAL AGE; PREECLAMPSIA; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY;

ACTIVINS; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INHIBIN-BETA SUBUNITS; INHIBINS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS; RETROSPECTIVE STUDIES;

EID: 0037276468     PISSN: 10641955     EISSN: None     Source Type: Journal    
DOI: 10.1081/PRG-120016794     Document Type: Article

References (42)

1. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
2. Hughes G, Bischof P, Wilson G, Smith R, Klopper A. Assay of placental protein to determine fetal risk. Brit J Med 1980; 280:671-673.
3. Toop K, Klopper A. Concentration of pregnancy-assocated plasma protein A (PAPP-A) in patients with pre-eclamptic toxaemia. Placenta 1981; 4(Suppl.):167-174.
4. Westergaard JG, Teisner B. Pregnancy-associated plasma protein A in normal and abnormal late pregnancy. In: Grudzinskas JG, Teisner B, Seppala M, eds. Pregnancy Proteins. Sydney: Academic Press, 1982; 345-354.
5. Bischof P. Placental proteins: pregnancy-associated plasma protein A. Contrib Gynecol Obstet 1984:12:41-73.
6. Oxvig C, Sand O, Kristensen T, Kristensen L, Sottrup-Jensen L. Isolation and characterisation of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta 1994; 1201:415-423.
7. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, et al. Expression of recombinant human pregnancy-associated plasma protein A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 2000; 275:31128-31133.
8. Bersinger NA, Altermatt HJ, Birkhäuser MH, Brizot ML, Kappeler A, Muller MD, et al. Non-placental production of pregnancy-associated placental protein A (PAPP-A): old and new evidence. Early Preg Biol Med 1997; 3:96-101.
9. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein A. Proc Natl Acad Sci USA 1999; 96:3149-3153.
10. Bischof P. Placental proteins: schwangerschaftsprotein 1. Contrib Gynecol Obstet 1984; 12:6-22.
11. 1-glycoprotein as a screening test for at-risk pregnancies. Am J Obstet Gynecol 1981; 141:499-502.
12. Muttukrishna S, Child TJ, Groome NP, Ledger WL. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy. Hum Reprod 1997; 12:1089-1093.
13. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for preeclampsia. Lancet 1997; 349:1285-1288.
14. Silver HM, Lambert GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, pre-eclamptic, and non-proteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol 1999; 180:1131-1137.
15. Aquilina J, Barnett A, Thompson O, Harrington K. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. Am J Obstet Gynecol 1999; 181:131-136.
16. Cuckle H, Sehmi I, Jones R. Maternal serum inhibin A can predict preeclampsia. Brit J Obstet Gynaecol 1998; 105:1101-1103.
17. Muttukrishna S, North RA, Morris J, Schellenberg JC, Taylor RS, Asselin J, et al. Serum inhibin A and activin A are elevated prior to the onset of preeclampsia. Hum Reprod 2000; 15:1640-1645.
18. Sebire NJ, Roberts L, Noble P, Wallace E, Nicolaides KH. Raised maternal serum inhibin A concentration at 10 to 14 weeks gestation is associated with preeclampsia. Brit J Obstet Gynaecol 2000; 107:795-797.
19. Raty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. Prediction of preeclampsia with maternal mid-trimester total renin, inhibin A, AFP and free β-hCG levels. Prenat Diagn 1999; 19:122-127.
20. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180:499-506.
21. Suefuiji H, Ogawa H, Yasue H, Sakamoto T, Miyao Y, Kaikita K, et al. Increased plasma level of soluble E-selectin in acute myocardial infarction. Am Heart J 2000; 140:243-248.
22. Austgulen R, Lien E, Vince G, Redman CW. Increased maternal plasma levels of soluble adhesion molecues (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 71:53-58.
23. Krauss T, Kuhn W, Lakoma C, Augustin HG. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997; 177:443-449.
24. Heyl W, Handt S, Reister F, Gehlen J, Schroder W, Mittermayer C, et al. Elevated soluble adhesion molecules in women with preeclampsia. Do cytokines like tumour necrosis factor-alpha and interleukin-1beta cause endothelial activation. Eur J Obstet Gynecol Reprod Biol 1999; 86:35-41.
25. Fickling SA, Whitley GS, Nussey SS. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia: does this indicate the mechanism of leucocyte activation? Brit J Obstet Gynaecol 1995; 102:173.
26. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JC. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia: does this indicate the mechanism of leucocyte activation. Brit J Obstet Gynaecol 1994; 101:485-487.
27. Halim A, Kanayama N, El Maradny E, Nakashima A, Bhuiyan AB, Khatun S, Terao T. Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances. Am J Obstet Gynecol 1996; 174: 272-277.
28. Daniel Y, Kupferminc MJ, Baram A, Jaffa AJ, Wolman I, Shenhav M, et al. Plasma soluble endothelial selectin is elevated in women with preeclampsia. Hum Reprod 1998; 13:3537-3541.
29. Bersinger NA, Zakher A, Huber U, Pescia G, Schneider H. A sensitive immunoassay for pregnancy-associated plasma protein A (PAPP-A): a possible first trimester method of screening for Down syndrome and other trisomies. Arch Gynecol Obstet 1995; 256:185-192.
30. Bersinger NA, Brandenberger AW, Birkhäuser MH. Endometrial and placental protein markers and ovarian steroids in serum during in-vitro fertilisation cycles. Hum Reprod 1995; 10:2149-2154.
31. Bueler M, Bersinger NA. Antiserum to pregnancy-associated plasma protein A (PAPP-A) recognizes human haptoglobin. Brit J Obstet Gynaecol 1989; 96:867-869.
32. Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganesan TS, Baird DT, et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site immunoassay. Clin Endocrinol 1994; 40:717-723.
33. Knight PG, Muttukrishna S, Groome NP. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin A concentrations in serum and follicular fluid. J Endocrinol 1996; 148:267-279.
34. Muttukrishna S, Tannetta D, Groome N, Redman C, Sargent I. Secretion of activin A by peripheral blood mononuclear cells (PBMCs) in culture and flowcytometric detection of intra cytoplasmic inhibin/activin subunits and activin receptors. International workshop on inhibins, activins, and follistatins, Melbourne, Australia, October 2000. Mol Cell Endocrinol (special edition) 2001; 180:194.
35. Brauman JN, Smith AI, Scheerlinck JP, de Kretser DM, Phillips DJ. Activin A and follistatin responses to inflammatory mediators in the endothelium. Proceedings of the 11th International Congress of Endocrinology. Sydney: The International Society for Endocrinology, 2000; Abstract P.512.
36. Lyall F, Greer IA. Reply to "The cell adhesion molecule, VCAM-1, is selectively elevated in serum in preeclampsia: Does this indicate the mechanism of leucocyte activation? by S.A. Fickling, G.S. Whitley, and S.S. Nussey". Brit J Obstet Gynaecol 1995; 102:173-174.
37. Kvasnicka J, Skrha J, Perusicova J, Kvasnicka T, Markova M, Umlaufova A, et al. Haemostasis, cytoadhesive molecules (sE-selectin and sICAM-1) and inflammatory markers in non-insulin dependent diabetes mellitus (NIDDM). Sb Lek 1998; 99: 97-101.
38. Szepietowski J, Wasik F, Bielicka E, Nockowski P, Noworolska A. Soluble E-selectin serum levels correlate with disease activity in psoriatic patients. Clin Exp Dermatol 1999; 24:33-36.
39. Galley HF, Blaylock MG, Dubbles AM, Webster NR. Variability in E-selectin expression, mRNA levels and sE-selectin release between endothelial cell lines and primary endothelial cells. Cell Biol Int 2000; 24:91-99.
40. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. Brit J Obstet Gynaecol 2000; 107:1265-1270.
41. Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein A and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab 2002; 87:1762-1767.
42. Bersinger NA, Marguerat P, Pescia G, Schneider H. Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay, importance of first trimester serum determinations, and stability studies. Reprod Fertil Dev 1995; 7:1419-1423.